In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 1st, 2008 | 30 | Yes |
Popular Name: N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide N-(2-Aminophenyl)-4-([[4-(pyridi…
Find On: PubMed — Wikipedia — Google
CAS Numbers: 726169-73-9 , 944537-89-7 , [726169-73-9]
726169-73-9; D09641; Mocetinostat (USAN/INN)
944537-89-7; D09357; Mocetinostat dihydrobromide (USAN)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.94 | 8.89 | -15.21 | 4 | 7 | 0 | 106 | 396.454 | 6 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Indications | antileukemia | KeyOrganics Bioactives |
Target | HDAC | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HDA11-1-E | Histone Deacetylase 11 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 590 | 0.29 | Binding ≤ 10μM |
HDAC1-2-E | Histone Deacetylase 1 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 9 | 0.38 | Binding ≤ 10μM |
HDAC2-1-E | Histone Deacetylase 2 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 32 | 0.35 | Binding ≤ 10μM |
HDAC3-1-E | Histone Deacetylase 3 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 620 | 0.29 | Binding ≤ 10μM |
CP3A4-2-E | Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 570 | 0.29 | ADME/T ≤ 10μM |
Z80682-2-O | A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other | Other | 900 | 0.28 | Functional ≤ 10μM |
Z80928-3-O | HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other | Other | 600 | 0.29 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HDAC1_HUMAN | Q13547 | Histone Deacetylase 1, Human | 130 | 0.32 | Binding ≤ 1μM |
HDA11_HUMAN | Q96DB2 | Histone Deacetylase 11, Human | 590 | 0.29 | Binding ≤ 1μM |
HDAC2_HUMAN | Q92769 | Histone Deacetylase 2, Human | 180 | 0.31 | Binding ≤ 1μM |
HDAC3_HUMAN | O15379 | Histone Deacetylase 3, Human | 265 | 0.31 | Binding ≤ 1μM |
HDAC1_HUMAN | Q13547 | Histone Deacetylase 1, Human | 130 | 0.32 | Binding ≤ 10μM |
HDA11_HUMAN | Q96DB2 | Histone Deacetylase 11, Human | 590 | 0.29 | Binding ≤ 10μM |
HDAC2_HUMAN | Q92769 | Histone Deacetylase 2, Human | 180 | 0.31 | Binding ≤ 10μM |
HDAC3_HUMAN | O15379 | Histone Deacetylase 3, Human | 1660 | 0.27 | Binding ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 900 | 0.28 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 1000 | 0.28 | Functional ≤ 10μM |
CP3A4_HUMAN | P08684 | Cytochrome P450 3A4, Human | 570 | 0.29 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Aflatoxin activation and detoxification | |
BMAL1:CLOCK,NPAS2 activates circadian gene expression | |
Circadian Clock | |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |
deactivation of the beta-catenin transactivating complex | |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | |
Factors involved in megakaryocyte development and platelet production | |
formation of the beta-catenin:TCF transactivating complex | |
G0 and Early G1 | |
HDACs deacetylate histones | |
NoRC negatively regulates rRNA expression | |
NOTCH1 Intracellular Domain Regulates Transcription | |
p75NTR negatively regulates cell cycle via SC1 | |
PPARA activates gene expression | |
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alp | |
repression of WNT target genes | |
REV-ERBA represses gene expression | |
RNA Polymerase I Transcription Initiation | |
RORA activates circadian gene expression | |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
Transcriptional activation of mitochondrial biogenesis | |
Transcriptional regulation of white adipocyte differentiation | |
Xenobiotics |
No pre-computed analogs available. Try a structural similarity search.